In line with this, Epstein et al. showed that an ALK5i was able to reduce α-SMA and type I collagen mRNA levels after 24 h in normal fibroblasts cultivated in an IPF conditioned matrix [49]. This evidence concerns the gene ACTA1 and idiopathic pulmonary fibrosis.